We found that NF-κB gene sets were induced by ambrosin in our GSEA analysis of bladder cancer and breast cancer cells, and that the expression of p65 protein is also induced by ambrosin in breast cancer cells, indicating that the NF-κB axis may also be a therapeutic target for further ambrosin studies. The gene discussed is NFKB1; the disease is urinary bladder carcinoma.